ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.641,30
0,25%
S&P 500
5.477,90
0,16%
US Dollar vs BRL
5,5238
0,00%
Bitcoin
61.078,53
0,44%
Brent Oil
84,305
-0,20%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) Notícias

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIB
DataHoraFonteTítuloCódigoCompanhia
24/06/202408:00GlobeNewswire Inc.Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM SensorNASDAQ:TRIBTrinity Biotech PLC
10/06/202410:10GlobeNewswire Inc.Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes AssociationNASDAQ:TRIBTrinity Biotech PLC
03/06/202405:00GlobeNewswire Inc.Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated TechnologyNASDAQ:TRIBTrinity Biotech PLC
28/05/202408:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
23/05/202409:00GlobeNewswire Inc.Trinity Biotech Announces Q1 2024 Financial Results and Reiterates GuidanceNASDAQ:TRIBTrinity Biotech PLC
16/05/202410:18GlobeNewswire Inc.Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAINASDAQ:TRIBTrinity Biotech PLC
13/05/202412:42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
08/05/202411:36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
08/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
07/05/202417:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
04/04/202408:30GlobeNewswire Inc.Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesNASDAQ:TRIBTrinity Biotech PLC
28/03/202419:39GlobeNewswire Inc.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
08/03/202412:03GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:TRIBTrinity Biotech PLC
15/02/202414:34GlobeNewswire Inc.Trinity Biotech Plc Finalizes Effective Date of ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
13/02/202411:00GlobeNewswire Inc.Trinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
09/02/202421:51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TRIBTrinity Biotech PLC
08/02/202410:30GlobeNewswire Inc.Trinity Biotech to Present at Emerging Growth ConferenceNASDAQ:TRIBTrinity Biotech PLC
07/02/202410:30GlobeNewswire Inc.Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeNASDAQ:TRIBTrinity Biotech PLC
31/01/202409:05GlobeNewswire Inc.Trinity Biotech Announces Q3 2023 Financial Results & Business UpdateNASDAQ:TRIBTrinity Biotech PLC
31/01/202409:02GlobeNewswire Inc.Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaNASDAQ:TRIBTrinity Biotech PLC
31/01/202409:00GlobeNewswire Inc.Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.NASDAQ:TRIBTrinity Biotech PLC
30/01/202419:23GlobeNewswire Inc.Trinity Biotech plc to Host Investor CallNASDAQ:TRIBTrinity Biotech PLC
02/01/202418:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
27/12/202310:57GlobeNewswire Inc.Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaNASDAQ:TRIBTrinity Biotech PLC
18/12/202318:30GlobeNewswire Inc.Trinity Biotech Announces Management ChangesNASDAQ:TRIBTrinity Biotech PLC
28/11/202318:05GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesNASDAQ:TRIBTrinity Biotech PLC
10/10/202309:15GlobeNewswire Inc.Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of HealthNASDAQ:TRIBTrinity Biotech PLC
03/10/202310:15GlobeNewswire Inc.Trinity Biotech Announces Q2 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
03/10/202308:58IH Market NewsTuesday’s Wall Street Highlights: GM, Airbnb, Tesla, Apple, Oddity Tech, and moreNASDAQ:TRIBTrinity Biotech PLC
27/09/202313:50GlobeNewswire Inc.Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIB

Seu Histórico Recente

COIN
UTTGBP
TG
BTW
Brown and Brown
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados